Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling
Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrat...
Gespeichert in:
Veröffentlicht in: | PLoS pathogens 2014-02, Vol.10 (2), p.e1003960-e1003960 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e1003960 |
---|---|
container_issue | 2 |
container_start_page | e1003960 |
container_title | PLoS pathogens |
container_volume | 10 |
creator | van Gent, Michiel Braem, Steven G E de Jong, Annemieke Delagic, Nezira Peeters, Janneke G C Boer, Ingrid G J Moynagh, Paul N Kremmer, Elisabeth Wiertz, Emmanuel J Ovaa, Huib Griffin, Bryan D Ressing, Maaike E |
description | Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts. |
doi_str_mv | 10.1371/journal.ppat.1003960 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1507832924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A364854202</galeid><doaj_id>oai_doaj_org_article_7a3f141db34946119f8c45c72780d9fc</doaj_id><sourcerecordid>A364854202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</originalsourceid><addsrcrecordid>eNqVks1u1DAUhSMEoqXwBggssYFFBjt2EmdTqa1aGGkEiJ-15XGuMx4SO9hOgWfgpXE606ojsUGRlej6OyfX1yfLnhO8ILQmb7du8lb2i3GUcUEwpk2FH2THpCxpXtOaPbz3fZQ9CWGLMSOUVI-zo4KVvCIVO87-XI4hgrH5ufQeXRs_BdRL3wGK0E0D2IhG72YCnX9aXRGknI3erKcIAUWHjLUyAjLDMFlAcC2DcRbFjXdTt0m7EbwGD1YB-mniJkn6Pu_Nd0AeFIzReRRMl85hbPc0e6RlH-DZ_n2Sfbu6_HrxPl99fLe8OFvlqsY05o3GknGGGciqUYXkrAXG9RrXUPK5RHhZ6LTWJVScEdUSwBWRbVNorFpMT7KXO9-xd0Hs5xgEKXHNadEULBHLHdE6uRWjN4P0v4WTRtwUnO-E9NGoHkQtqSaMtGvKGlYR0miuWKnqoua4bbRKXqf7v03rAVqVRuplf2B6uGPNRnTuWtCG4rKZ2329N_DuxwQhisEEBX0vLbjppm9GqqJic9-vdmgnU2vGapcc1YyLM1oxXrICF4la_INKTwuDSfcL2qT6geDNgWDOAPyKnZxCEMsvn_-D_XDIsh2rvAvBg76bCsFiDvnt5Yg55GIf8iR7cX-id6LbVNO_McL6uQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504162644</pqid></control><display><type>article</type><title>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>PubMed Central</source><creator>van Gent, Michiel ; Braem, Steven G E ; de Jong, Annemieke ; Delagic, Nezira ; Peeters, Janneke G C ; Boer, Ingrid G J ; Moynagh, Paul N ; Kremmer, Elisabeth ; Wiertz, Emmanuel J ; Ovaa, Huib ; Griffin, Bryan D ; Ressing, Maaike E</creator><contributor>Coscoy, Laurent</contributor><creatorcontrib>van Gent, Michiel ; Braem, Steven G E ; de Jong, Annemieke ; Delagic, Nezira ; Peeters, Janneke G C ; Boer, Ingrid G J ; Moynagh, Paul N ; Kremmer, Elisabeth ; Wiertz, Emmanuel J ; Ovaa, Huib ; Griffin, Bryan D ; Ressing, Maaike E ; Coscoy, Laurent</creatorcontrib><description>Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1003960</identifier><identifier>PMID: 24586164</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Biology ; Enzyme-Linked Immunosorbent Assay ; Epstein-Barr virus ; Epstein-Barr Virus Infections - immunology ; Epstein-Barr Virus Infections - metabolism ; Flow Cytometry ; Fluorescent Antibody Technique ; Herpesvirus 4, Human ; Herpesviruses ; Host-bacteria relationships ; Humans ; Immune Evasion - immunology ; Immune response ; Immune system ; Immunity, Innate ; Immunoblotting ; Infections ; Medical research ; Microbiological research ; Physiological aspects ; Signal Transduction - immunology ; Toll-like receptors ; Toll-Like Receptors - immunology ; Toll-Like Receptors - metabolism ; Transfection ; Viral infections ; Viral Regulatory and Accessory Proteins - immunology ; Viral Regulatory and Accessory Proteins - metabolism</subject><ispartof>PLoS pathogens, 2014-02, Vol.10 (2), p.e1003960-e1003960</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 van Gent et al 2014 van Gent et al</rights><rights>2014 van Gent et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: van Gent M, Braem SGE, de Jong A, Delagic N, Peeters JGC, et al. (2014) Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling. PLoS Pathog 10(2): e1003960. doi:10.1371/journal.ppat.1003960</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</citedby><cites>FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,2106,2932,23875,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24586164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Coscoy, Laurent</contributor><creatorcontrib>van Gent, Michiel</creatorcontrib><creatorcontrib>Braem, Steven G E</creatorcontrib><creatorcontrib>de Jong, Annemieke</creatorcontrib><creatorcontrib>Delagic, Nezira</creatorcontrib><creatorcontrib>Peeters, Janneke G C</creatorcontrib><creatorcontrib>Boer, Ingrid G J</creatorcontrib><creatorcontrib>Moynagh, Paul N</creatorcontrib><creatorcontrib>Kremmer, Elisabeth</creatorcontrib><creatorcontrib>Wiertz, Emmanuel J</creatorcontrib><creatorcontrib>Ovaa, Huib</creatorcontrib><creatorcontrib>Griffin, Bryan D</creatorcontrib><creatorcontrib>Ressing, Maaike E</creatorcontrib><title>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.</description><subject>Biology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Infections - immunology</subject><subject>Epstein-Barr Virus Infections - metabolism</subject><subject>Flow Cytometry</subject><subject>Fluorescent Antibody Technique</subject><subject>Herpesvirus 4, Human</subject><subject>Herpesviruses</subject><subject>Host-bacteria relationships</subject><subject>Humans</subject><subject>Immune Evasion - immunology</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity, Innate</subject><subject>Immunoblotting</subject><subject>Infections</subject><subject>Medical research</subject><subject>Microbiological research</subject><subject>Physiological aspects</subject><subject>Signal Transduction - immunology</subject><subject>Toll-like receptors</subject><subject>Toll-Like Receptors - immunology</subject><subject>Toll-Like Receptors - metabolism</subject><subject>Transfection</subject><subject>Viral infections</subject><subject>Viral Regulatory and Accessory Proteins - immunology</subject><subject>Viral Regulatory and Accessory Proteins - metabolism</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNqVks1u1DAUhSMEoqXwBggssYFFBjt2EmdTqa1aGGkEiJ-15XGuMx4SO9hOgWfgpXE606ojsUGRlej6OyfX1yfLnhO8ILQmb7du8lb2i3GUcUEwpk2FH2THpCxpXtOaPbz3fZQ9CWGLMSOUVI-zo4KVvCIVO87-XI4hgrH5ufQeXRs_BdRL3wGK0E0D2IhG72YCnX9aXRGknI3erKcIAUWHjLUyAjLDMFlAcC2DcRbFjXdTt0m7EbwGD1YB-mniJkn6Pu_Nd0AeFIzReRRMl85hbPc0e6RlH-DZ_n2Sfbu6_HrxPl99fLe8OFvlqsY05o3GknGGGciqUYXkrAXG9RrXUPK5RHhZ6LTWJVScEdUSwBWRbVNorFpMT7KXO9-xd0Hs5xgEKXHNadEULBHLHdE6uRWjN4P0v4WTRtwUnO-E9NGoHkQtqSaMtGvKGlYR0miuWKnqoua4bbRKXqf7v03rAVqVRuplf2B6uGPNRnTuWtCG4rKZ2329N_DuxwQhisEEBX0vLbjppm9GqqJic9-vdmgnU2vGapcc1YyLM1oxXrICF4la_INKTwuDSfcL2qT6geDNgWDOAPyKnZxCEMsvn_-D_XDIsh2rvAvBg76bCsFiDvnt5Yg55GIf8iR7cX-id6LbVNO_McL6uQ</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>van Gent, Michiel</creator><creator>Braem, Steven G E</creator><creator>de Jong, Annemieke</creator><creator>Delagic, Nezira</creator><creator>Peeters, Janneke G C</creator><creator>Boer, Ingrid G J</creator><creator>Moynagh, Paul N</creator><creator>Kremmer, Elisabeth</creator><creator>Wiertz, Emmanuel J</creator><creator>Ovaa, Huib</creator><creator>Griffin, Bryan D</creator><creator>Ressing, Maaike E</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140201</creationdate><title>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</title><author>van Gent, Michiel ; Braem, Steven G E ; de Jong, Annemieke ; Delagic, Nezira ; Peeters, Janneke G C ; Boer, Ingrid G J ; Moynagh, Paul N ; Kremmer, Elisabeth ; Wiertz, Emmanuel J ; Ovaa, Huib ; Griffin, Bryan D ; Ressing, Maaike E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Infections - immunology</topic><topic>Epstein-Barr Virus Infections - metabolism</topic><topic>Flow Cytometry</topic><topic>Fluorescent Antibody Technique</topic><topic>Herpesvirus 4, Human</topic><topic>Herpesviruses</topic><topic>Host-bacteria relationships</topic><topic>Humans</topic><topic>Immune Evasion - immunology</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity, Innate</topic><topic>Immunoblotting</topic><topic>Infections</topic><topic>Medical research</topic><topic>Microbiological research</topic><topic>Physiological aspects</topic><topic>Signal Transduction - immunology</topic><topic>Toll-like receptors</topic><topic>Toll-Like Receptors - immunology</topic><topic>Toll-Like Receptors - metabolism</topic><topic>Transfection</topic><topic>Viral infections</topic><topic>Viral Regulatory and Accessory Proteins - immunology</topic><topic>Viral Regulatory and Accessory Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Gent, Michiel</creatorcontrib><creatorcontrib>Braem, Steven G E</creatorcontrib><creatorcontrib>de Jong, Annemieke</creatorcontrib><creatorcontrib>Delagic, Nezira</creatorcontrib><creatorcontrib>Peeters, Janneke G C</creatorcontrib><creatorcontrib>Boer, Ingrid G J</creatorcontrib><creatorcontrib>Moynagh, Paul N</creatorcontrib><creatorcontrib>Kremmer, Elisabeth</creatorcontrib><creatorcontrib>Wiertz, Emmanuel J</creatorcontrib><creatorcontrib>Ovaa, Huib</creatorcontrib><creatorcontrib>Griffin, Bryan D</creatorcontrib><creatorcontrib>Ressing, Maaike E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Gent, Michiel</au><au>Braem, Steven G E</au><au>de Jong, Annemieke</au><au>Delagic, Nezira</au><au>Peeters, Janneke G C</au><au>Boer, Ingrid G J</au><au>Moynagh, Paul N</au><au>Kremmer, Elisabeth</au><au>Wiertz, Emmanuel J</au><au>Ovaa, Huib</au><au>Griffin, Bryan D</au><au>Ressing, Maaike E</au><au>Coscoy, Laurent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>10</volume><issue>2</issue><spage>e1003960</spage><epage>e1003960</epage><pages>e1003960-e1003960</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24586164</pmid><doi>10.1371/journal.ppat.1003960</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-7374 |
ispartof | PLoS pathogens, 2014-02, Vol.10 (2), p.e1003960-e1003960 |
issn | 1553-7374 1553-7366 1553-7374 |
language | eng |
recordid | cdi_plos_journals_1507832924 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Public Library of Science (PLoS) Journals Open Access; PubMed Central |
subjects | Biology Enzyme-Linked Immunosorbent Assay Epstein-Barr virus Epstein-Barr Virus Infections - immunology Epstein-Barr Virus Infections - metabolism Flow Cytometry Fluorescent Antibody Technique Herpesvirus 4, Human Herpesviruses Host-bacteria relationships Humans Immune Evasion - immunology Immune response Immune system Immunity, Innate Immunoblotting Infections Medical research Microbiological research Physiological aspects Signal Transduction - immunology Toll-like receptors Toll-Like Receptors - immunology Toll-Like Receptors - metabolism Transfection Viral infections Viral Regulatory and Accessory Proteins - immunology Viral Regulatory and Accessory Proteins - metabolism |
title | Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T20%3A34%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epstein-Barr%20virus%20large%20tegument%20protein%20BPLF1%20contributes%20to%20innate%20immune%20evasion%20through%20interference%20with%20toll-like%20receptor%20signaling&rft.jtitle=PLoS%20pathogens&rft.au=van%20Gent,%20Michiel&rft.date=2014-02-01&rft.volume=10&rft.issue=2&rft.spage=e1003960&rft.epage=e1003960&rft.pages=e1003960-e1003960&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1003960&rft_dat=%3Cgale_plos_%3EA364854202%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504162644&rft_id=info:pmid/24586164&rft_galeid=A364854202&rft_doaj_id=oai_doaj_org_article_7a3f141db34946119f8c45c72780d9fc&rfr_iscdi=true |